ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Alto Neuroscience, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ANRO GlobeNewswire August 01, 2025 NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Alto Neuroscience, Inc. (NYSE: […]

Future of India – Forecast to 2035 | MarketsandMarkets(TM)

Future of India – Forecast to 2035 | MarketsandMarkets(TM) GlobeNewswire August 01, 2025 Delray Beach, FL, July 31, 2025 (GLOBE NEWSWIRE) — According to MarketsandMarkets(TM), “Future of India – Forecast to 2035″ offers a comprehensive analysis of the mega trends propelling India's growth by 2035. It also includes an extensive coverage of growth opportunities in

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement

(TSX-V:STUD),(Boerse Frankfurt – Freiverkehr:HM40.F),(OTC US:STLNF),(Other OTC:STLNF),(Frankfurt:FE0), NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion“) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) further to its news release of July 8th, 2025, the Company provides certain

Diplomatic Trade Ltd, Thomas J. Kent Jr. the Kent Family Office, and Kent Global LLC Stake Acquisition in Turkish Pharma Firm, Target $300M UAE Biopharma Venture

Thomas J. Kent Jr. DUBAI, United Arab Emirates, July 31, 2025 (GLOBE NEWSWIRE) — Diplomatic Trade Ltd and Kent Global Support Strategic Stake in Turkish Pharma Group, Plan $300M UAE Biopharma Initiative Cross-border biopharma venture targets UAE facility launch in Q3 2025 and public listing by year-end Diplomatic Trade Ltd, a cross-border trade and investment

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement

Stallion Uranium Announces Update to Previously Announced Technology Licensing Agreement GlobeNewswire August 01, 2025 NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion“) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) further to its news release

Diplomatic Trade Ltd, Thomas J. Kent Jr. the Kent Family Office, and Kent Global LLC Stake Acquisition in Turkish Pharma Firm, Target $300M UAE Biopharma Venture

Diplomatic Trade Ltd, Thomas J. Kent Jr. the Kent Family Office, and Kent Global LLC Stake Acquisition in Turkish Pharma Firm, Target $300M UAE Biopharma Venture Cross-border biopharma venture targets $300M IPO valuation and UAE facility launch by Q3 2025 GlobeNewswire August 01, 2025 Thomas J. Kent Jr. DUBAI, United Arab Emirates, July 31, 2025

APhA Deeply Concerned with ACIP Secretariat for Undermining Pharmacist Representation

The American Pharmacists Association (APhA) is deeply concerned with the Advisory Committee on Immunization Practices (ACIP) Secretariat's decision to label Liaison organizations as a “special interest groups” and therefore, “biased” in decision-making. https://mma.prnewswire.com/media/1483899/American_Pharmacists_Association_Logo.jpg APhA has served as a non-biased Liaison organization with pharmacists, who are free from conflict of interest, voluntarily serving as scientific advisors

RWA Group Secures Strategic Investment from Meta Strategy to Accelerate RWA Ecosystem Growth

RWA Group Limited, a leading real-world asset (RWA) tokenization and infrastructure service provider based in Hong Kong, today announced it has secured a strategic investment from Meta Strategy, aimed at accelerating its growth and strengthening its position in the rapidly expanding RWA sector across Asia. Meta Strategy's investment offers more than funding, bringing extensive industry

Class Action Filed Against Centene Corporation (CNC) Over Securities Violations – Contact Levi & Korsinsky Today

NEW YORK CITY, NY / ACCESS Newswire / July 31, 2025 / If you suffered a loss on your Centene Corporation (NYSE:CNC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/centene-corporation-lawsuit-submission-form?prid=159170&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Scroll to Top